Target intelligence / Profile preview

Gastric microbiota

Molecular classification
Other
01

Overview

The gastric microbiota refers to the complex and dynamic ecosystem of bacteria, viruses, and fungi residing in the stomach, which was once thought to be sterile due to its high acidity [6, 11]. This community plays a vital role in maintaining gastric homeostasis by modulating local immune responses, aiding in nutrient metabolism, and providing a barrier against the colonization of exogenous pathogens [2, 10]. Helicobacter pylori is the most prominent member of this microbiota and is a major risk factor for chronic gastritis, peptic ulcers, and gastric adenocarcinoma via the action of virulence factors such as CagA and VacA [6, 19]. Recent research indicates that dysbiosis involving other microbial taxa, such as Fusobacterium and Lactobacillus, also contributes to carcinogenesis and affects the host's response to treatments like immunotherapy [2, 12]. Pharmacological agents, including antibiotics and proton pump inhibitors, significantly remodel the gastric microbial composition, which can in turn alter drug bioavailability and toxicity [1, 15]. Therapeutic interventions such as probiotics, prebiotics, and fecal microbiota transplantation are being investigated as strategies to restore microbial balance and improve clinical outcomes in gastrointestinal diseases [7, 10, 12].

Other names
Gastric microbiomeStomach floraStomach microbiotaGastric bacterial community
02

Mechanism of action

Eradication of pathogenic species (e.g., H. pylori), restoration of microbial diversity, modulation of the tumor immune microenvironment, competitive inhibition of pathogens, and production of beneficial metabolites such as short-chain fatty acids (SCFAs).

03

Biological functions

Immune responseDigestionMetabolismPathogen protectionMaintenance of mucosal barrierEndocrine balanceSignal transduction
04

Disease associations

CancerInflammationInfectionPeptic ulcer diseaseMALT lymphomaDysbiosisFunctional dyspepsia
05

Safety considerations

Antibiotic-induced dysbiosisAntibiotic resistanceRisk of opportunistic infections (e.g., Clostridioides difficile)Systemic translocation of bacteriaUncertain long-term effects of fecal microbiota transplantation
06

Interacting drugs

Amoxicillin

8 more in the full profile.

07

Biomarkers

16S rRNA microbial profilingMicrobial alpha diversityHelicobacter pylori colonization (CagA/VacA status)Fusobacterium nucleatum abundancePeptostreptococcus abundanceLactobacillus abundance

Beyond the preview

Go deeper on Gastric microbiota.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastric microbiota.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call